About Cytokinetics (CYTK)
Cytokinetics Inc. is a late-stage biopharmaceutical company. The Company is focused on discovering, developing and commercializing first-in-class muscle activators as potential treatments for debilitating diseases in which muscle performance is compr... Read more
- USD40.50
- USD41.87
- USD40.50
- USD68.44
- -9.20%
- 18M
- 104.00
- 2.33M
- 4.8B
- 32.74
- -37.60%
Stock News
7 hours ago
Trump to ease impact of tariffs on U.S. automakers, Lutnick says
MarketWatch
yesterday
Continued job growth could help ward off a recession, Jim Cramer says
CNBC
yesterday
Cramer becomes increasingly bullish on Boeing after adding the stock to the Bullpen
CNBC
yesterday
Are the storm clouds finally starting to part for portfolio stock Apple?
CNBC
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
